V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009951 | 270005854 | 1 | 50.5 | Disease modification (D) | 2013-08-08 | 2013-08-15 | R ABVD | N | N | 270021973 | CVP R |
| 270009952 | 270005854 | 1.58 | 79.6 | Palliative (P) | 2016-11-30 | 2016-12-02 | DHAP | 02 | null | 270021973 | CVP R |
| 270009953 | 270005855 | 1.65 | 72 | Curative (C) | 2016-05-10 | 2016-05-23 | Rituximab | N | N | 270022008 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009954 | 270005856 | 1.81 | 72.1 | Curative (C) | 2019-01-11 | 2019-02-08 | Bendamustine+Rituximab(Sub Courses) | N | N | 270022026 | CISPLATIN + GEMCITABINE |
| 270009955 | 270005857 | null | 104 | Palliative (P) | null | 2014-05-21 | CVP R | null | null | 270022029 | GDP |
| 270009956 | 270005857 | 1.6 | 74 | Palliative (P) | 2017-01-13 | 2017-03-01 | CHOP - 21 days | N | N | 270022029 | CAPECITABINE + CISPLATIN |
| 270009957 | 270005858 | 1.78 | 90.3 | Curative (C) | 2015-12-12 | 2016-01-02 | Rituximab | N | N | 270022048 | CVP R |
| 270009958 | 270005859 | 1.62 | 60 | Curative (C) | 2015-07-10 | 2015-07-12 | Brentuximab | 02 | N | 270022064 | ABVD R |
| 270009959 | 270012889 | 1.6 | 55.3 | Curative (C) | null | 2017-03-06 | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + ETOPOSIDE | N | N | 270022072 | CVP R |
| 270009960 | 270012889 | 1.83 | 109 | Curative (C) | 2013-05-21 | 2013-05-21 | null | N | N | 270022072 | CVP R |
| 270009961 | 270005860 | 1.74 | 83.7 | null | 2017-03-08 | 2017-03-30 | CAPECITABINE + CARBOPLATIN | 2 | N | 270022078 | CAP + RT |
| 270009962 | 270005860 | 1.67 | 69.3 | Curative (C) | 2017-03-31 | 2017-04-27 | null | N | N | 270022078 | CVP R |
| 270009963 | 270005861 | 1.59 | 51.9 | Adjuvant (A) | null | 2015-10-09 | DHAP - R | null | null | 270022091 | BREVITY TRIAL |
| 270009964 | 270005861 | 1.64 | null | Curative (C) | null | 2013-06-20 | Carboplatin+Fluorouracil 4 or 5 day | null | null | 270022091 | CVP R |
| 270009965 | 270005862 | null | 73.1 | Curative (C) | 2016-08-30 | 2016-09-25 | Chlorambucil + Pred + Vinblastine | N | N | 270022115 | NOT MATCHED |
| 270009966 | 270005862 | 1.62 | 58 | Curative (C) | 2017-12-16 | 2017-12-17 | GDP | 02 | N | 270022115 | BREVITY TRIAL |
| 270009967 | 270005863 | 1.55 | 47.4 | Adjuvant (A) | 2013-07-07 | 2013-07-08 | ECHELON-1 TRIAL | N | N | 270022128 | NOT MATCHED |
| 270009968 | 270005863 | null | null | Curative (C) | null | 2015-06-23 | CVP R | null | null | 270022128 | CVP R |
| 270009969 | 270005864 | 1.75 | 76.5 | Curative (C) | 2017-02-25 | 2017-04-01 | CVP R | N | N | 270022133 | ABVD R |
| 270009970 | 270005864 | null | 70.6 | Disease modification (D) | 2013-03-30 | 2013-05-09 | Rituximab | N | N | 270022133 | NOT MATCHED |
| 270009971 | 270005864 | 1.81 | 49 | Not known (9) | 2016-12-19 | 2016-12-29 | Cetuximab + FOLFIRI cycle1 | N | N | 270022133 | VINBLASTINE |
| 270009972 | 270005865 | null | null | Curative (C) | 2014-10-29 | 2014-11-15 | Vinblastine | N | N | 270022153 | BRENTUXIMAB |
| 270009973 | 270005865 | 1.67 | null | null | null | 2014-04-23 | GDP | N | N | 270022153 | NOT MATCHED |
| 270009974 | 270005866 | 1.78 | 87.4 | Adjuvant (A) | 2013-11-24 | 2013-11-27 | PACIFICO TRIAL | 02 | N | 270022166 | CHOP |
| 270009975 | 270005866 | 1.78 | 131.6 | Palliative (P) | 2016-11-29 | 2016-11-30 | Brentuximab | N | N | 270022166 | CHLORAMBUCIL |
| 270009976 | 270005866 | 1.52 | 58.2 | Adjuvant (A) | null | 2016-08-09 | DOXORUBICIN + ETOPOSIDE + VINCRISTINE | N | N | 270022166 | CVP R |
| 270009977 | 270005867 | null | null | Curative (C) | 2017-03-30 | 2017-04-03 | CVP R | N | N | 270022183 | NOT MATCHED |
| 270009978 | 270005867 | 1.65 | 62 | Disease modification (D) | null | 2014-09-02 | Brentuximab | null | null | 270022183 | BRENTUXIMAB |
| 270009979 | 270005867 | 1.62 | 63 | Curative (C) | 2014-06-24 | 2014-07-06 | CVP R | 02 | N | 270022183 | DACARBAZINE |
| 270009980 | 270005867 | 1.6 | 73 | Curative (C) | 2014-09-08 | 2014-09-15 | null | 02 | N | 270022183 | BRENTUXIMAB |
| 270009981 | 270005868 | null | 64.1 | Neo-adjuvant (N) | null | 2014-04-13 | Rituximab | null | null | 270022214 | ESHAP |
| 270009982 | 270012898 | 1.76 | 71 | Curative (C) | 2017-07-13 | 2017-07-22 | CVP R | 2 | N | 270022215 | CODOX M |
| 270009983 | 270005869 | 1.71 | 89 | Curative (C) | 2014-10-25 | 2014-11-16 | Carboplatin AUC 6 - 10 | N | N | 270022216 | IBRUTINIB |
| 270009984 | 270012899 | 1.56 | 65 | T | 2017-04-14 | 2017-04-18 | CVP R | N | N | 270022218 | NOT MATCHED |
| 270009985 | 270016065 | 1.71 | 75.4 | Curative (C) | 2016-01-20 | 2016-01-20 | MELPHALAN + RITUXIMAB | Y | N | 270022244 | VINBLASTINE |
| 270009986 | 270016065 | 1.77 | 55 | Curative (C) | 2015-04-11 | 2015-04-20 | CHLORAMBUCIL + Procarbazine + VINBLASTINE + VINORELBINE | N | N | 270022244 | NOT MATCHED |
| 270009987 | 270005870 | null | 63.8 | Palliative (P) | 2014-01-22 | 2014-01-30 | GEM-P | N | N | 270022249 | NOT MATCHED |
| 270009988 | 270005870 | 1.68 | 70.9 | Curative (C) | 2015-08-21 | 2015-08-28 | ChIVPP/EVA | N | N | 270022249 | ABVD R |
| 270009989 | 270016066 | 1.62 | null | Disease modification (D) | 2017-06-21 | 2017-07-13 | Enzalutamide | N | N | 270022269 | CARBO + FLUOROURACIL |
| 270009990 | 270005871 | 1.6 | 71.9 | Curative (C) | 2015-12-01 | 2015-12-09 | HD Lymph Pred EuroNet-PHL-LP1 CVP | 2 | N | 270022272 | RITUXIMAB |
| 270009991 | 270005872 | 1.67 | null | Curative (C) | 2013-08-20 | 2013-09-17 | Cisplatin + Fluorouracil + RT 5day | null | null | 270022274 | NOT MATCHED |
| 270009992 | 270005873 | null | 80 | Curative (C) | 2014-07-16 | 2014-08-12 | null | N | N | 270022281 | ABVD R |
| 270009993 | 270005873 | 1.61 | 59.7 | Disease modification (D) | 2013-08-20 | 2013-09-05 | Chlorambucil | 2 | N | 270022281 | IMATINIB |
| 270009994 | 270005874 | 1.61 | null | null | null | 2013-07-29 | Brentuximab | null | null | 270022283 | CARBOPLATIN + ETOPOSIDE |
| 270009995 | 270005874 | null | null | Curative (C) | 2015-05-17 | 2015-05-25 | ECHELON 1 TRIAL | N | null | 270022283 | ESHAP R |
| 270009996 | 270005875 | 1.89 | 74 | Curative (C) | 2013-05-06 | 2013-05-13 | CVP R | Y | N | 270022305 | DHAP |
| 270009997 | 270005876 | 1.74 | 68.7 | Neo-adjuvant (N) | 2015-05-25 | 2015-05-28 | BREVITY TRIAL | 02 | N | 270022307 | VEDEX |
| 270009998 | 270005876 | 1.78 | 62.6 | Curative (C) | 2013-09-28 | 2013-10-04 | CVP | N | N | 270022307 | CETUXIMAB + IRINOTECAN + MDG |
| 270009999 | 270016067 | 1.8 | 93 | Disease modification (D) | 2015-06-07 | 2015-06-07 | Cetuximab +Cisplatin + FU (Cycle 1) | 01 | N | 270022312 | VINBLASTINE |
| 270010000 | 270016067 | 1.7 | 114.2 | Disease modification (D) | 2017-05-26 | 2017-11-10 | Brentuximab | N | N | 270022312 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |